The Sauber F1 team has made a huge announcement, declaring its plans to set up a new technical center in the United Kingdom. The new Motorsport Technology Cente ...

Audi F1 announce major update with new UK hub ahead of 2026 entry - Sauber, transitioning to become Audi next year, have ...

The Democratic National Committee elected Ken Martin as its chair on Saturday afternoon, as the party looks to new leadership to help steer it through President Donald Trump’s second term in office.

WASHINGTON, Feb 1 (Reuters) - Looking to rebuild after the party's election loss to Donald Trump in November, the Democratic National Committee on Saturday elected Ken Martin, the leader of the ...

Minnesota politics is back in the national spotlight this weekend. State DFL Party Chair Ken Martin is now the chair of the Democratic National Committee, in charge of recruiting and organizing ...

Editor in Chief B2B COMPUTERWOCHE, CIO, CSO in Germany Martin Bayer is Editor in Chief B2B COMPUTERWOCHE, CIO, CSO in Germany. He specializes in business software: Business Intelligence ...

Editor in Chief B2B COMPUTERWOCHE, CIO, CSO in Germany Martin Bayer is Editor in Chief B2B COMPUTERWOCHE, CIO, CSO in Germany. He specializes in business software: Business Intelligence ...

Bayer was founded in the year 1863 in Barmen in North Rhine Westphalia in the west of what was then the Kingdom of Prussia, today modern Germany. "What started as a small but innovative dyestuffs ...

OXON HILL, Md. — Democrats on Saturday elected Ken Martin, the party leader in Minnesota, as the national chair, turning to a low-profile Midwestern political operative to coordinate their ...

Sauber is opening a new Formula 1 facility in a third country to try and improve its fortunes. There’s a very specific aim ...

This is the top model in the Audi RS Q8 line-up and holds the title ... and we expect the RS Q8 to cost north of Rs 1.6 crore in India. The Aston Martin Vanquish is returning after six years.

Bayer has advanced its small-molecule drug BAY 2927088 into phase 3 for non-small cell lung cancer (NSCLC) with HER2 activating mutations, one of the drugs central to the company’s plan to ...